Logo of the Federal Ministry for Economic Affairs and Energy
Made in Germany logo
WHX Johannesburg 2026German Exhibitors DRM-Pharma & Diagnostik GmBH

DRM-Pharma & Diagnostik GmBH

Booth number: H2.F31
drm-management.com

About us

Define Resources & Management (DRM Pharma & Diagnostic) is an international healthcare and clinical research partner focused on advancing pharmaceutical, diagnostic, and healthcare solutions through innovation, expertise, and strategic collaboration.

Our core capabilities span Pharmaceutical & Diagnostic Products, Clinical Research, Healthcare Consultancy, and Outsourcing Services, enabling us to support organizations across the healthcare value chain from product development and market access to operational execution and strategic growth.

At DRM Pharma & Diagnostic, we combine industry expertise with innovative technologies and tailored solutions to address the evolving needs of the global healthcare sector. Our approach is built around quality, innovation, collaboration, and long-term value creation.

Through our growing portfolio of healthcare technologies and strategic partnerships, DRM is committed to connecting science, technology, and healthcare to create practical solutions for better health outcomes and a more accessible future.

DRM Pharma & Diagnostic GmbH - Connecting Innovation with Healthcare.

Address

DRM-Pharma & Diagnostik GmBH
Odenwaldring 41
63110 Rodgau
Germany

E-mail: dr@drm-management.de
Phone:  +49 6106 6978263
Internet: drm-management.com

Contact person:

Dr Ghulam Murtaza Randhawah
CEO
E-mail: dr@drm-management.de
Phone: +49 171 3204193

Products & Services

Consulting Services in Healthcare
Diagnostics
Medical Technology

Chlorin E6 Photodynamic Therapy

A scientifically grounded, minimally invasive approach to advanced wound care.

Chlorin E6–based Photodynamic Therapy (PDT) offers a promising antibiotic-sparing approach for the management of chronic and diabetic wounds. Clinical observations and documented cases have demonstrated accelerated wound healing alongside significant reductions in bacterial load in diabetic ulcers treated with PDT–Chlorin E6 protocols.

With documented chronic-wound healing outcomes exceeding 89% in reported cases, this innovative therapy represents a clinically credible complement to conventional wound-care strategies, particularly in an era of growing antimicrobial resistance.

My German Pavilion

  • Manage your personal profile here and enter your desired business contacts to German companies
  • Keep an eye on the trade fairs, German exhibitors and products that are of interest to you
  • Receive an e-mail notification on relevant upcoming German trade fair presentations
Sign up now